This is a StreetInsider.com Premium Only Page

Genomic Health (GHDX) – Company Press Releases

Nov 8, 2019 08:03 AM Exact Sciences Completes Combination with Genomic Health, Creating Leading Global Cancer Diagnostics Company

Nov 7, 2019 01:55 PM Genomic Health Stockholders Approve Proposed Acquisition by Exact Sciences

Nov 4, 2019 06:30 PM Shenandoah Telecommunications Set to Join S&P SmallCap 600

Sep 30, 2019 09:00 AM New TAILORx Data, Published Today in JAMA Oncology, Add to Strong Evidence Base Reinforcing Unique Ability of Oncotype DX Breast Recurrence Score® Test to Guide Chemotherapy Treatment

Aug 21, 2019 08:00 AM New St. Gallen International Breast Cancer Guidelines Recommend Oncotype DX Breast Recurrence Score® Test to Guide Chemotherapy for Node-negative and Node-positive Early-stage Breast Cancer

Jul 29, 2019 04:08 PM Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Genomic Health, Inc. (NASDAQ: GHDX) on Behalf of Genomic Shareholders and Encourages Genomic Investors to Contact the Firm

Jul 29, 2019 07:01 AM Genomic Health Reports 19% Revenue Growth and Record Profit in Second Quarter 2019, Raises Full-Year Guidance

Jul 29, 2019 07:00 AM Exact Sciences and Genomic Health to Combine, Creating Leading Global Cancer Diagnostics Company

Jul 25, 2019 08:00 AM Genomic Health to Announce Second Quarter 2019 Financial Results and Host Conference Call on Thursday, August 1, 2019

Jul 23, 2019 06:17 PM Genomic Health Set to Join S&P SmallCap 600

Jun 20, 2019 01:00 PM German Federal Joint Committee (G-BA) Issues Exclusive Nationwide Reimbursement Decision for Oncotype DX Breast Recurrence Score® Test

Jun 6, 2019 04:05 PM Clovis Oncology Names Ginger L. Graham as New Board of Directors Chair

Jun 3, 2019 11:45 AM Secondary Analysis of Landmark TAILORx Results, Published Today in The New England Journal of Medicine, Affirms Unique Ability of Oncotype DX Breast Recurrence Score® to Predict Chemotherapy Benefit,

Jun 3, 2019 08:00 AM Updated ASCO Guidelines Establish TAILORx-defined Cutoffs for Determining Chemotherapy Benefit with the Oncotype DX Breast Recurrence Score® Test in Node-negative Breast Cancer

May 29, 2019 08:00 AM Genomic Health to Present at the Jefferies 2019 Healthcare Conference

May 7, 2019 04:05 PM Genomic Health Reports First Quarter 2019 Financial Results and Recent Business Progress

Apr 30, 2019 08:00 AM Genomic Health to Announce First Quarter 2019 Financial Results and Host Conference Call on Tuesday, May 7, 2019

Mar 25, 2019 08:00 AM New Long-term Outcomes Data Presented at St. Gallen International Breast Cancer Conference Reinforce TAILORx Treatment Paradigm and Standard of Care Use for Oncotype DX Breast Recurrence Score® Test

Feb 28, 2019 01:01 AM Biocartis Group NV: BIOCARTIS ANNOUNCES 2018 RESULTS AND 2019 OUTLOOK

Feb 28, 2019 01:00 AM Biocartis Group NV: BIOCARTIS ANNOUNCES 2018 RESULTS AND 2019 OUTLOOK

Feb 20, 2019 04:05 PM Genomic Health Reports Record 2018 Fourth Quarter and Year-end Financial Results and Provides 2019 Financial Guidance

Feb 13, 2019 08:00 AM Genomic Health to Announce Fourth Quarter and Year-End 2018 Financial Results and Host Conference Call on Wednesday, February 20, 2019

Feb 5, 2019 08:00 AM Oncotype DX® Genomic Prostate Score® Established as First Genomic Test with Prospective Validation for Predicting Adverse Pathology in Newly Diagnosed Patients

Jan 7, 2019 08:00 AM Genomic Health Marks More than 1 Million Patients Worldwide Who Have Benefited from Oncotype DX Testing in Personalizing Cancer Treatment Decisions to Improve Outcomes

Dec 19, 2018 08:00 AM NICE Expands Recommendation for the Oncotype DX Breast Recurrence Score® Test to More Patients with Early-Stage Breast Cancer Within the United Kingdom

Dec 18, 2018 08:00 AM Genomic Health to Present at the 37th Annual J.P. Morgan Healthcare Conference

Dec 10, 2018 08:00 AM Multiple Oncotype DX Study Presentations at the 2018 San Antonio Breast Cancer Symposium Reinforce Real-world Value of the Oncotype DX Breast Recurrence Score® Test in Patients Regardless of Age or R

Dec 3, 2018 04:51 PM Genomic Health and Biocartis Expand Collaboration to Urology with the Development of an Idylla™ Oncotype DX® Genomic Prostate Score® Test

Nov 29, 2018 08:00 AM New Analysis of NSABP Randomized B-20 Study Confirms Patients with Oncotype DX Breast Recurrence Score® Results Greater Than 25 Have Life-saving Substantial Benefit from Chemotherapy, Reinforcing the

Nov 19, 2018 08:00 AM Genomic Health Announces Presentation of Two Large Studies at the 2018 San Antonio Breast Cancer Symposium, Reinforcing Real-world Value of the Oncotype DX Breast Recurrence Score® Test

Nov 8, 2018 08:00 AM Genomic Health to Present at the 2018 Canaccord Genuity Medical Technologies & Diagnostics Forum

Nov 6, 2018 04:05 PM Genomic Health Announces Record Revenue and Profit in Third Quarter 2018 Financial Results; Raises Full Year Guidance

Oct 30, 2018 08:00 AM Genomic Health to Announce Third Quarter 2018 Financial Results and Host Conference Call on Tuesday, November 6, 2018

Oct 29, 2018 08:00 AM Medicare Establishes Final Local Coverage Determination (LCD) for Use of the Oncotype DX® AR-V7 Nucleus Detect™ Test in Patients with Metastatic Castrate Resistant Prostate Cancer Effective Decembe

Oct 22, 2018 08:00 AM Genomic Health Announces Multiple Studies Reinforcing Value of Oncotype DX® Tests in Guiding Treatment for Breast and Prostate Cancer Patients

Oct 9, 2018 04:15 PM New NCCN Breast Cancer Guidelines Elevate Oncotype DX Breast Recurrence Score® as the Only Preferred Multi-gene Test to Predict Chemotherapy Treatment

Sep 28, 2018 08:00 AM New Published Data and Recent Positive Private Payor Coverage Decisions Underscore Value and Utility of the Oncotype DX Genomic Prostate Score® (GPS™) Test

Sep 12, 2018 08:00 AM Epic Sciences Announces Completion of $52 Million Series E Financing

Sep 7, 2018 08:00 AM German Health Technology Assessment Body (IQWiG) Concludes Only Oncotype DX® has Sufficient Evidence to Guide Breast Cancer Adjuvant Chemotherapy Decisions Based on Landmark TAILORx Study Results

Sep 6, 2018 01:01 AM Biocartis Group NV: BIOCARTIS ANNOUNCES H1 2018 RESULTS

Sep 6, 2018 01:00 AM Biocartis Group NV: BIOCARTIS ANNOUNCES H1 2018 RESULTS

Aug 2, 2018 04:05 PM Genomic Health Announces Second Quarter 2018 Financial Results and Reports Recent Business Progress

Jul 26, 2018 08:00 AM Genomic Health to Announce Second Quarter 2018 Financial Results and Host Conference Call on Thursday, August 2, 2018

Jun 28, 2018 11:00 AM Blood Test Predicts Treatment Response and Survival for Patients with Metastatic Prostate Cancer

Jun 3, 2018 07:30 AM Landmark TAILORx Results, Published Today in The New England Journal of Medicine, Demonstrate the Oncotype DX Breast Recurrence Score® Test Definitively Identifies the 70% of Women with Early-stage B

May 30, 2018 08:00 AM Genomic Health to Present at Jefferies 2018 Global Healthcare Conference

May 29, 2018 08:00 AM Merchavia Reports Positive Results in a Breakthrough Trial for Early Prostate Cancer Diagnosis

May 21, 2018 08:00 AM New Data Reinforce Positive Impact of the Oncotype DX® Genomic Prostate Score™ Test in Guiding Treatment Decisions

May 9, 2018 08:00 AM Genomic Health to Present at Bank of America Merrill Lynch 2018 Health Care Conference

May 2, 2018 04:05 PM Genomic Health Announces First Quarter 2018 Financial Results and Reports Recent Business Progress